Document is current

Article History

Received: 18 October 2024

Accepted: 20 January 2025

First Online: 27 January 2025

Declarations

:

: The study protocol complied with the “Ethical Guidelines for Medical Research Involving Human Subjects” and was approved by the ethics review committee of the Graduate School of Pharmaceutical Science, Osaka University (Approval number: Yakuhito2023-1). Informed consent to participate in the study was obtained from all participants as follows: Participants were informed that submitting their responses indicated consent to the study. The survey was anonymous, and results were aggregated to ensure confidentiality. Additionally, the study’s purpose, question details, time required, and confidentiality were clearly explained before consent was given.

: Not applicable.

: The authors declare no competing interests.